McClaren, B.J., King, E.A., Crellin, E., Gaff, C., Metcalfe, S.A., & Nisselle, A. (2020). Development of an Evidence-Based, Theory-Informed National Survey of Physician Preparedness for Genomic Medicine and Preferences for Genomics Continuing Education. Frontiers in Genetics.
Richmond, C.M., Campbell, S., Foo, H.W., Lunke, S., Stark, Z., Moody, A., et al. (2020). Mol Syndromol, 11(1), 50-55.
Best, S., Stark, Z., Phillips, P., Wu, Y., Long, J.C., Taylor, N., et al. (2020). Clinical genomic testing: what matters to key stakeholders? Eur J Hum Genet.
Byrne, A.B., Mizumoto, S., Arts, P., Yap, P., Feng, J., Schreiber, A.W., et al. (2020). Pseudodiastrophic dysplasia expands the known phenotypic spectrum of defects in proteoglycan biosynthesis. J Med Genet.
Prictor, M., Lewis, M.A., Newson, A.J., Haas, M., Baba, S., Kim, H., et al. (2019). Dynamic Consent: An Evaluation and Reporting Framework. J Empir Res Hum Res Ethics. [ePub ahead of print].
Haas, M.A., Boughtwood, T.F., & Quinn, M.C. (2019). The ethics approval process for multisite research studies in Australia: changes sought by the Australian Genomics initiative. Med J Aust, 211(10), 440-444.e441.
Nisselle, A., Martyn, M., Jordan, H., Kaunein, N., McEwen, A., Patel, C., et al. (2019). Ensuring Best Practice in Genomic Education and Evaluation: A Program Logic Approach. 10(1057).
Byrne AB, Arts P, Polyak SW, Feng J, Schreiber AW, Kassahn KS, et al. (2019). Identification and targeted management of a neurodegenerative disorder caused by biallelic mutations in SLC5A6. NPJ Genom Med.
Rius, R., Van Bergen, N.J., Compton, A.G., Riley, L.G., Kava, M.P., Balasubramaniam, S., et al. (2019). Clinical Spectrum and Functional Consequences Associated with Bi-Allelic Pathogenic PNPT1 Variants. J Clin Med, 8(11).
Boughtwood T, for Australian Genomics (October 2019).